Early Data From Ionis/Biogen’s BIIB080 Keeps Tau Alzheimer’s Hopes Alive

Unique Antisense Approach To Tau

 
• By Andrew McConaghie
  
Ionis HQ
Preclinical studies showed BIIB080 could prevent or even reverse Alzheimer's in transgenic mice - but the Phase I study did not examine clinical efficacy in humans.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip